U.S., May 21 -- ClinicalTrials.gov registry received information related to the study (NCT06980948) titled 'Safety and Tolerability Study of ST-503 for Small Fiber Neuropathy-associated Refractory Pain' on April 30.
Brief Summary: This research is being done to study a possible treatment for refractory pain due to small fiber neuropathy (iSFN).
ST-503 is intended to deliver a modified copy of the gene which will ideally repress Nav1.7 tissue-related pain signals reaching the brain, which should reduce the refractory pain due to small fiber neuropathy (iSFN).
Study Start Date: July, 2025
Study Type: INTERVENTIONAL
Condition:
Chronic Neuropathic Pain
Intervention:
GENETIC: ST-503
Genomic Medicine
PROCEDURE: Sham (No Treatment)
Sham...